CoreMed
Business Services · 11-50 Employees
View Company Info for Free
Overview
Phone Number
+81 352052757Website
www.coremed.co.jpRevenue
$6.2 MillionIndustry
About CoreMed
CoreMed Org Chart
Is CoreMed your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if CoreMed is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at CoreMed
Funding: Get notified immidiatlly once CoreMed has new funding data
Product Launch: Get notified when CoreMed launches new products
CoreMed, which may be a good buyer, showed buying intent in Masked Content Topic
Check if CoreMed has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on CoreMed recently announced quarterly report
Website visits: Recent activity has been detected on your website
Click to see if CoreMed had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined CoreMed as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
CoreMed is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
CoreMed is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about CoreMed.
CoreMed Tech Stack
A closer look at the technologies used by CoreMed
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CoreMed
CoreMed Co., Ltd. is a regulatory and development strategy consulting firm specializing in pharmaceutical development. They provide comprehensive support for all stages of drug development, from early development to approval, including regulatory strategy, clinical and non-clinical development, and CMC. The company collaborates with reliable allian... Read More